Viewpoints » Visby Medical Will Exhibit at the APHL 2022 Annual Conference

04/08/2022 • Viewpoint

Visby Medical Will Exhibit at the APHL 2022 Annual Conference

Visby Medical Will Exhibit at the APHL 2022 Annual Conference, a hybrid event for the public health laboratory (PHL) community.

Visby Medical Will Exhibit at the APHL 2022 Annual Conference

APHL 2022 Annual Conference

May 17-20, 2022

Huntington Convention Center of Cleveland
300 Lakeside Ave E, Cleveland, OH 441131

The APHL Annual Conference, a hybrid event for the public health laboratory (PHL) community, brings together leaders, scientists, influencers and partners to share issues, trends and best practices driving laboratory science and public health today. Session topics explore public health laboratory issues, trends and technologies relative to COVID-19 and other emerging infectious diseases, environmental health, emergency preparedness, quality systems and safety, informatics, food safety, newborn screening, global health and more.

Visby Medical Will Exhibit at the APHL 2022 Annual Conference

Visit our booth #506 to hold our revolutionary palm-sized PCR for three critical sexual health targets — chlamydia, gonorrhea, and trichomonas.

Register

Learn more about the Visby Medical Sexual Health Test

Read more articles & insights

05/11/2023 • Viewpoint

Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected

As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May 11, 2023, it is essential to understand how the healthcare industry has adapted and evolved to address the unique challenges posed by the COVID-19 pandemic.

Read More
Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected

03/14/2023 • Press Release

Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women

Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of care (POC) test.

Read More
Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women

01/03/2023 • Press Release

Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings

Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.

Read More
Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings

06/10/2023 • Viewpoint

Everything You Need to Know about Trichomonas Featuring Dr. Ina Park

CME on-demand webinar presented by ASHA | A comprehensive guide for the detection and management of the often neglected sexually transmitted infection, Trichomoniasis.

Read More
Everything You Need to Know about Trichomonas Featuring Dr. Ina Park